Profile
Stephen Hitchcock is currently a Director at both the Structural Genomics Consortium and Cerevance, Inc. Previously, he worked as an Executive Director-Medicinal Chemistry at Amgen, Inc., a Principal at Eli Lilly & Co., and a Senior Vice President-Drug Discovery at Envoy Therapeutics, Inc. He holds a doctorate degree from The University of Nottingham.
Stephen Hitchcock active positions
| Companies | Position | Start |
|---|---|---|
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that determines three-dimensional structures of proteins of medical relevance | Director/Board Member | - |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Director/Board Member | - |
Former positions of Stephen Hitchcock
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Corporate Officer/Principal | - |
Training of Stephen Hitchcock
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Envoy Therapeutics, Inc.
Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Health Technology |
Structural Genomics Consortium
Structural Genomics Consortium Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that determines three-dimensional structures of proteins of medical relevance | Commercial Services |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutics for neurological and psychiatric disorders | Health Technology |
- Stock Market
- Insiders
- Stephen Hitchcock
















